Retinoic Acid Market Research Report 2018, Industry Forecast to 2023

Retinoic Acid Market by Mode of Administration (Oral, and External) and by End User (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Retinoic acid is a metabolite of vitamin A (retinol) that mediates the functions of vitamin A required for growth and development. It is a member of family of retinoids, that are compound either derived from vitamin A or are structurally similar to it.

Get the full report: https://www.futureindustryinsight.com/product/retinoic-acid-market-research-report-2018/

Rise in incidences of cancers as retinoids find an important application in cancer therapeutics drive the market. In addition, retinoic acid is widely used for the treatment of photoaged skin, psoriasis, skin lesions of Kaposis sarcoma, and for cancers of breast and prostate also fuel the market growth. However, isotretinoin; a form of retinoic acid; is highly teratogenic.

As teratogenic drug can disturb the development of an embryo, therefore the use of retinoic acid is strictly controlled. This restrains the market growth. Conversely, increase in research for the cure of cancers and advancements in cancer therapeutics provide ample opportunities for the market growth.

The retinoic acid market is segmented on the basis of mode of administration, end user, and region. Based on mode of administration, the market is categorized into oral retinoids and external retinoids. By end user, it is classified into hospital pharmacy, retail pharmacy, and online pharmacy. By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players operating in the market include LGM Pharma, GF Health Products, Inc., GYMA Laboratories of America, Inc., Genemed Synthesis Inc., IMCoPharma a. s., Chongqing Huabang Pharmacy Co., Ltd., Olon S.p.A., and Sun Pharmaceutical Industries Ltd.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which explains the competitive outlook of the global market.
  • The report offers a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.

Get the full report: https://www.futureindustryinsight.com/product/retinoic-acid-market-research-report-2018/

About Us: 

FutureIndustryInsight™ provides quantified B2B research on 20,000 high growth emerging opportunities/threats which will impact 75% to 85% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 70,000 top officers across eight industries worldwide approach FutureIndustryInsight™ for their painpoints around revenues decisions.

Media Contact:

Name: Rahul

Designation: Global Sales Manager

Ph: +17132421323

Email: [email protected]

Web: https://www.futureindustryinsight.com/